Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado Florida Cancer Specialists-Lake Nona, Orlando, Florida START Midwest, Grand Rapids, Michigan Washington University, St Louis, Missouri Nebraska Cancer Specialists, Omaha, Nebraska Carolina BioOncology Institute, Huntersville, North Carolina Cleveland Clinic, Cleveland, Ohio Taylor Cancer Research Center, Maumee, Ohio University of Pennsylvania, Philadelphia, Pennsylvania NEXT Oncology - Dallas, Dallas, Texas START San Antonio, San Antonio, Texas START Mountain Region, West Valley City, Utah NEXT Virginia, Fairfax, Virginia